Phase II of ALS Stem Cell Trial Underway at Emory and University of Michigan – HispanicBusiness.com
|
Phase II of ALS Stem Cell Trial Underway at Emory and University of Michigan
HispanicBusiness.com Researchers at Emory University and University of Michigan have begun the Phase II trial of a landmark study to treat patients with Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) using human neural stem cells. The Phase II dose escalation … |
